{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:36:37Z","timestamp":1790487397034,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.det.2012.08.010","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T06:16:43Z","timestamp":1349158603000},"page":"93-108","source":"Crossref","is-referenced-by-count":84,"title":["Alopecia Areata Update"],"prefix":"10.1016","volume":"31","author":[{"given":"Abdullah","family":"Alkhalifah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2012.08.010_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata","volume":"46","author":"Wasserman","year":"2007","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1525-1470.2002.00215.x","article-title":"Alopecia areata in children: a clinical profile","volume":"19","author":"Nanda","year":"2002","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib5","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1111\/1523-1747.ep12471869","article-title":"Alopecia areata: clinical aspects","volume":"96","author":"Price","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"14","key":"10.1016\/j.det.2012.08.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940601101X","article-title":"Alopecia areata: pathogenesis and potential for therapy","volume":"8","author":"Lu","year":"2006","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2012.08.010_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-4632.2008.03584.x","article-title":"A\u00a0case of patchy alopecia areata sparing lesional greying hairs","volume":"47","author":"Tan","year":"2008","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaad.2008.08.045","article-title":"Acute diffuse and total alopecia: a new subtype of alopecia areata with a favorable prognosis","volume":"60","author":"Lew","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000066435","article-title":"Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis","volume":"205","author":"Sato-Kawamura","year":"2002","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/0019-5154.84768","article-title":"Utility of dermoscopy in alopecia areata","volume":"56","author":"Mane","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaad.2006.04.058","article-title":"Videodermoscopy in the evaluation of hair and scalp disorders","volume":"55","author":"Ross","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2008.03.031","article-title":"The role of scalp dermoscopy in the diagnosis of alopecia areata incognita","volume":"59","author":"Tosti","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib14","first-page":"114","article-title":"Nail changes in alopecia areata: incidence and pattern","volume":"69","author":"Gandhi","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1468-3083.2008.02830.x","article-title":"Nail changes in alopecia areata: frequency and clinical presentation","volume":"23","author":"Kasumagic-Halilovic","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2012.08.010_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-5945-5-11","article-title":"Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients","volume":"5","author":"Seyrafi","year":"2005","journal-title":"BMC Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib17","first-page":"123","article-title":"Thyroid autoimmunity in patients with alopecia areata","volume":"16","author":"Kasumagic-Halilovic","year":"2008","journal-title":"Acta Dermatovenerol Croat"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1087-0024.2004.00835.x","article-title":"Autoimmunity: alopecia areata","volume":"9","author":"Hordinsky","year":"2004","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"9","key":"10.1016\/j.det.2012.08.010_bib19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1468-3083.2006.01676.x","article-title":"Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history","volume":"20","author":"Goh","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jaad.2009.10.024","article-title":"Alopecia areata and autoimmunity","volume":"62","author":"Rosenstein","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib21","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1542\/peds.2011-0142","article-title":"Intermediate uveitis and alopecia areata: is there a relationship? Report of 3 pediatric cases","volume":"128","author":"Ayuso","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.1320510313","article-title":"Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA)","volume":"51","author":"Wang","year":"1994","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-4362.2003.01340.x","article-title":"Alopecia areata: psychiatric comorbidity and adjustment to illness","volume":"42","author":"Ruiz-Doblado","year":"2003","journal-title":"Int J Dermatol"},{"issue":"Pt 5","key":"10.1016\/j.det.2012.08.010_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/eye.1999.174","article-title":"Ocular alterations in alopecia areata","volume":"13","author":"Recupero","year":"1999","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.det.2012.08.010_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.2002.tb04229.x","article-title":"Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity","volume":"966","author":"Elenkov","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2008.02.005","article-title":"Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis","volume":"59","author":"Rodriguez","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000254233","article-title":"Produced alopecia areata based on the focal infection theory and mental motive theory","volume":"134","author":"Ikeda","year":"1967","journal-title":"Dermatologica"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1034\/j.1600-0625.2001.100605.x","article-title":"Melanocyte and gonad activity as potential severity modifying factors in C3H\/HeJ mouse alopecia areata","volume":"10","author":"McElwee","year":"2001","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib29","first-page":"11","article-title":"Genetic susceptibility and severity of alopecia areata in human and animal models","volume":"11","author":"McElwee","year":"2001","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8019.2011.01411.x","article-title":"The genetics of alopecia areata: what's new and how will it help our patients?","volume":"24","author":"Petukhova","year":"2011","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1529-8019.2011.01416.x","article-title":"Etiopathogenesis of alopecia areata: why do our patients get it?","volume":"24","author":"Wang","year":"2011","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1529-8019.2011.01413.x","article-title":"Alopecia areata: clinical presentation, diagnosis, and unusual cases","volume":"24","author":"Finner","year":"2011","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2012.08.010_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(84)70152-6","article-title":"T\u00a0cell subpopulations in alopecia areata","volume":"11","author":"Todes-Taylor","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1529-8019.2011.01414.x","article-title":"Histopathology of alopecia areata, acute and chronic: why is it important to the clinician?","volume":"24","author":"Dy","year":"2011","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.det.2012.08.010_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.139.12.1555","article-title":"Histopathologic features of alopecia areata: a new look","volume":"139","author":"Whiting","year":"2003","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2013Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib39","first-page":"441","volume":"9","author":"Kalkoff","year":"1958","journal-title":"Hautarzt"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","article-title":"Alopecia areata: evidence-based treatments","volume":"28","author":"Garg","year":"2009","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004413.pub2","article-title":"Interventions for alopecia areata","author":"Delamere","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","article-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","volume":"88","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1971.tb07230.x","article-title":"A\u00a0comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata","volume":"85","author":"Porter","year":"1971","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib44","first-page":"674","article-title":"Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs","volume":"71","author":"Kubeyinje","year":"1994","journal-title":"East Afr Med J"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib45","first-page":"909","article-title":"Treatment of severe alopecia areata with intralesional steroid injections","volume":"8","author":"Chang","year":"2009","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0733-8635(05)70017-6","article-title":"Hair regrowth. Therapeutic agents","volume":"16","author":"Shapiro","year":"1998","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib47","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbrc.2007.03.065","article-title":"Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells","volume":"356","author":"Sohn","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000252466","article-title":"Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform response","volume":"141","author":"Pascher","year":"1970","journal-title":"Dermatologica"},{"issue":"7","key":"10.1016\/j.det.2012.08.010_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1468-3083.2006.01781.x","article-title":"Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial","volume":"20","author":"Tosti","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archderm.136.10.1276","article-title":"Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream","volume":"136","author":"Charuwichitratana","year":"2000","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib53","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.1987.tb07505.x","article-title":"Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia","volume":"117","author":"Bunker","year":"1987","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","article-title":"Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography","volume":"82","author":"Wester","year":"1984","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1346-8138.1990.tb01641.x","article-title":"The effect of topical minoxidil on hair follicular cycles of rats","volume":"17","author":"Mori","year":"1990","journal-title":"J\u00a0Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.det.2012.08.010_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0190-9622(87)70084-X","article-title":"Action of topical minoxidil in the bald stump-tailed macaque","volume":"16","author":"Uno","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1523-1747.ep12499788","article-title":"Potassium channel conductance: a mechanism affecting hair growth both in\u00a0vitro and in\u00a0vivo","volume":"98","author":"Buhl","year":"1992","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.det.2012.08.010_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.det.2012.08.010_bib61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib62","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.1986.01660140070020","article-title":"Topical minoxidil dose-response effect in alopecia areata","volume":"122","author":"Fiedler-Weiss","year":"1986","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A\u00a0randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A\u00a0randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib65","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A\u00a0multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib66","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archderm.1979.04010100058026","article-title":"Treatment of alopecia areata by anthralin-induced dermatitis","volume":"115","author":"Schmoeckel","year":"1979","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2012.08.010_bib67","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.1987.01660350091020","article-title":"Evaluation of anthralin in the treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0906-6705.2004.00098.x","article-title":"Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin","volume":"13","author":"Tang","year":"2004","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib69","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archderm.1990.01670300056006","article-title":"Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin","volume":"126","author":"Fiedler","year":"1990","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00128071-200506060-00007","article-title":"Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study","volume":"6","author":"Sasmaz","year":"2005","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00416931","article-title":"Antigenic competition as a therapeutic concept for alopecia areata","volume":"267","author":"Happle","year":"1980","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib72","first-page":"537","article-title":"Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00412926","article-title":"Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata","volume":"278","author":"Happle","year":"1986","journal-title":"Arch Dermatol Res"},{"issue":"5\u20136","key":"10.1016\/j.det.2012.08.010_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasylyszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00293811","article-title":"Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE)","volume":"45","author":"Strobel","year":"1980","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1218(80)90124-X","article-title":"1-Chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium","volume":"77","author":"Summer","year":"1980","journal-title":"Mutat Res"},{"issue":"5 Pt 1","key":"10.1016\/j.det.2012.08.010_bib78","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0190-9622(84)80456-9","article-title":"Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability","volume":"11","author":"Wilkerson","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2012.08.010_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0190-9622(85)70164-8","article-title":"Squaric acid and esters: analysis for contaminants and stability in solvents","volume":"13","author":"Wilkerson","year":"1985","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2012.08.010_bib80","doi-asserted-by":"crossref","first-page":"c3671","DOI":"10.1136\/bmj.c3671","article-title":"Management of alopecia areata","volume":"341","author":"Harries","year":"2010","journal-title":"BMJ"},{"issue":"5 Pt 1","key":"10.1016\/j.det.2012.08.010_bib81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2012.08.010_bib82","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.1994.tb00078.x","article-title":"Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients","volume":"11","author":"Orecchia","year":"1994","journal-title":"Pediatr Dermatol"},{"issue":"Suppl 5","key":"10.1016\/j.det.2012.08.010_bib84","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1038\/jid.1995.53","article-title":"Topical immunotherapy in children with alopecia areata","volume":"104","author":"Orecchia","year":"1995","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib85","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/039463201102400428","article-title":"Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment","volume":"24","author":"Ganzetti","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2012.08.010_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(91)70032-W","article-title":"Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000246337","article-title":"Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance","volume":"192","author":"Weise","year":"1996","journal-title":"Dermatology"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib88","first-page":"397","article-title":"Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA)","volume":"35","author":"Galadari","year":"2003","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.1996.tb06317.x","article-title":"Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up","volume":"134","author":"Gordon","year":"1996","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2011.01476.x","article-title":"Advances in the management of alopecia areata","volume":"39","author":"Ito","year":"2012","journal-title":"J\u00a0Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00643.x","article-title":"Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not","volume":"124","author":"Orecchia","year":"1991","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630410023601","article-title":"Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial","volume":"16","author":"Dall'oglio","year":"2005","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib93","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1600-0536.2002.4705102.x","article-title":"Urticaria after topical immunotherapy with diphenylcyclopropenone","volume":"47","author":"Francomano","year":"2002","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib95","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(99)70540-2","article-title":"Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata","volume":"40","author":"Alam","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib96","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0536.1989.tb04737.x","article-title":"Contact urticaria during topical immunotherapy","volume":"21","author":"Tosti","year":"1989","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000247976","article-title":"Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone","volume":"180","author":"Perret","year":"1990","journal-title":"Dermatologica"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.47102\/annals-acadmedsg.V38N3p276","article-title":"Vitiligo as an adverse reaction to topical diphencyprone","volume":"38","author":"Pan","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib99","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.1995.tb02692.x","article-title":"Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis","volume":"133","author":"Henderson","year":"1995","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1529-8019.2011.01419.x","article-title":"Topical and intralesional therapies for alopecia areata","volume":"24","author":"Alkhalifah","year":"2011","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib101","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.IOP.0000132175.30732.74","article-title":"Trichiasis associated with prostaglandin analog use","volume":"20","author":"Bearden","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"Suppl 5","key":"10.1016\/j.det.2012.08.010_bib102","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.jaad.2004.05.002","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","volume":"51","author":"Tosti","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib103","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0002-9394(03)01075-4","article-title":"Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost","volume":"137","author":"Hart","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib104","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-3083.2004.01020.x","article-title":"Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost","volume":"18","author":"Herane","year":"2004","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","article-title":"Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model","volume":"14","author":"Sasaki","year":"2005","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib106","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","volume":"60","author":"Roseborough","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib107","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib108","first-page":"586","article-title":"The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows","volume":"19","author":"Faghihi","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib109","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis","volume":"24","author":"Coronel-Perez","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0974-7753.77511","article-title":"Bimatoprost in the treatment of eyelash universalis alopecia areata","volume":"2","author":"Vila","year":"2010","journal-title":"Int J Trichol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib111","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2009.01.027","article-title":"Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata","volume":"61","author":"Ochoa","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib112","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib113","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb03309.x","article-title":"PUVA treatment for alopecia areata\u2013does it work? A retrospective review of 102 cases","volume":"129","author":"Healy","year":"1993","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib114","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0781.2011.00612.x","article-title":"Narrowband ultraviolet B phototherapy for alopecia areata","volume":"27","author":"Bayramgurler","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","article-title":"308-nm excimer laser therapy in alopecia areata","volume":"51","author":"Zakaria","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2012.08.010_bib116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1610-0387.2005.05710.x","volume":"3","author":"Raulin","year":"2005","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/lsm.20002","article-title":"Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser","volume":"34","author":"Gundogan","year":"2004","journal-title":"Lasers Surg Med"},{"issue":"12","key":"10.1016\/j.det.2012.08.010_bib118","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm Excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib119","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","article-title":"308-nm Excimer laser for the treatment of alopecia areata in children","volume":"26","author":"Al-Mutairi","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib120","doi-asserted-by":"crossref","first-page":"592.e1","DOI":"10.1016\/j.jaad.2009.02.037","article-title":"Phase I\/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata","volume":"61","author":"Talpur","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2012.08.010_bib121","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1468-3083.2009.03243.x","article-title":"Capsaicin vs. clobetasol for the treatment of localized alopecia areata","volume":"23","author":"Ehsani","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.det.2012.08.010_bib122","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-4632.2009.04230.x","article-title":"Treatment of alopecia areata with fractional photothermolysis laser","volume":"49","author":"Yoo","year":"2010","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib123","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10103-011-0953-7","article-title":"Effects of the Lexington LaserComb on hair regrowth in the C3H\/HeJ mouse model of alopecia areata","volume":"27","author":"Wikramanayake","year":"2012","journal-title":"Lasers Med Sci"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib124","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8\u20139","key":"10.1016\/j.det.2012.08.010_bib125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.annder.2010.06.002","volume":"137","author":"Ait Ourhroui","year":"2010","journal-title":"Ann Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2012.08.010_bib126","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"issue":"13","key":"10.1016\/j.det.2012.08.010_bib127","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.det.2012.08.010_bib128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","article-title":"Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata","volume":"26","author":"Sharma","year":"1999","journal-title":"J\u00a0Dermatol"},{"issue":"4 Pt 1","key":"10.1016\/j.det.2012.08.010_bib129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000092287","article-title":"A\u00a0comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib132","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0733-8635(05)70010-3","article-title":"The risks of systemic corticosteroid use","volume":"16","author":"Lester","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2012.08.010_bib133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CCID.S22767","article-title":"Alopecia areata: a new treatment plan","volume":"4","author":"Alsantali","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2012.08.010_bib134","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","article-title":"Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis","volume":"22","author":"Gupta","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0190-9622(97)70342-6","article-title":"Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation","volume":"36","author":"Shapiro","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib137","first-page":"90","article-title":"The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis","volume":"11","author":"Shaheedi-Dadras","year":"2008","journal-title":"Arch Iran Med"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib138","first-page":"415","article-title":"Multifocal alopecia areata during systemic cyclosporine A therapy","volume":"198","author":"Cerottini","year":"1999","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib139","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-0960.1996.tb01066.x","article-title":"Alopecia areata in a renal transplant recipient on cyclosporin","volume":"37","author":"Dyall-Smith","year":"1996","journal-title":"Australas J Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.det.2012.08.010_bib140","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.jaad.2005.03.005","article-title":"Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine","volume":"53","author":"Phillips","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib141","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.1995.tb00742.x","article-title":"Alopecia areata arising in patients receiving cyclosporin immunosuppression","volume":"132","author":"Davies","year":"1995","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib142","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.2009.00937.x","article-title":"Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids","volume":"19","author":"Lee","year":"2010","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib143","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1529-8019.2011.01420.x","article-title":"Systemic treatment for alopecia areata","volume":"24","author":"Otberg","year":"2011","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.det.2012.08.010_bib144","first-page":"252","article-title":"Topical cyclosporin A in alopecia areata","volume":"69","author":"Gilhar","year":"1989","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib145","first-page":"507","volume":"114","author":"Mauduit","year":"1987","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib146","first-page":"332","article-title":"Treatment of alopecia areata in the DEBR model using cyclosporin A lipid vesicles","volume":"14","author":"Verma","year":"2004","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib147","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2006.12.011","article-title":"Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient","volume":"33","author":"Ranganath","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib148","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mjd.2002.119671","article-title":"Sulfasalazine for alopecia areata","volume":"46","author":"Ellis","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib149","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/0378-6323.45103","article-title":"An uncontrolled, open label study of sulfasalazine in severe alopecia areata","volume":"74","author":"Aghaei","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8","key":"10.1016\/j.det.2012.08.010_bib150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-4632.2008.03700.x","article-title":"Treatment of persistent alopecia areata with sulfasalazine","volume":"47","author":"Rashidi","year":"2008","journal-title":"Int J Dermatol"},{"issue":"8\u20139","key":"10.1016\/j.det.2012.08.010_bib151","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annder.2010.06.031","volume":"137","author":"Chartaux","year":"2010","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib152","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib153","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","article-title":"Efficacy and tolerability of methotrexate in severe childhood alopecia areata","volume":"165","author":"Royer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib154","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2012.08.010_bib155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-4362.2001.01261-3.x","article-title":"Paroxetine in alopecia areata","volume":"40","author":"Cipriani","year":"2001","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib156","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2005.09.025","article-title":"Hypnotherapeutic management of alopecia areata","volume":"55","author":"Willemsen","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib157","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib158","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib159","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2230.2007.02367.x","article-title":"Lack of response of alopecia areata to pimecrolimus cream","volume":"32","author":"Rigopoulos","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib160","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib161","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000155502320624203","article-title":"Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis","volume":"82","author":"Park","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.det.2012.08.010_bib162","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-4632.2008.03327.x","article-title":"Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata","volume":"47","author":"Koc","year":"2008","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib163","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1468-3083.2002.00570_4.x","article-title":"Ineffectiveness of imiquimod therapy for alopecia totalis\/universalis","volume":"16","author":"D'Ovidio","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib164","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2000.03783.x","article-title":"Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","volume":"143","author":"Bissonnette","year":"2000","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.010_bib165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2230.2008.02712.x","article-title":"Failure to treat alopecia areata with photodynamic therapy","volume":"33","author":"Fernandez-Guarino","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2012.08.010_bib166","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archderm.142.12.1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","volume":"142","author":"Garcia Bartels","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.010_bib167","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following\u00a0adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib168","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib169","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.det.2012.08.010_bib170","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111523","article-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","volume":"216","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.det.2012.08.010_bib172","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.141.6.759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2005","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.010_bib173","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1540-9740.2006.05443.x","article-title":"Failure of two TNF-alpha blockers to influence the course of alopecia areata","volume":"5","author":"Abramovits","year":"2006","journal-title":"Skinmed"},{"issue":"2","key":"10.1016\/j.det.2012.08.010_bib174","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273940802596559","article-title":"Alopecia areata during etanercept therapy","volume":"17","author":"Pan","year":"2009","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T23:22:31Z","timestamp":1714432951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863512000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0733863512000988"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2012.08.010","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}